A study, published in The Lancet Oncology, reports large international differences in survival among patients diagnosed with 15 common cancer types in Asia, Africa, and Latin America and the Caribbean.
After the stunning success of mRNA vaccines during the COVID-19 pandemic, researchers and biotech companies are racing to prove the utility of the technology in an array of non-communicable diseases—including cancer, cystic fibrosis, and sickle cell disease.
